Search, analyze & compare
My selected companies
Adjust valuation method
![]()
Detail of Generation Bio Co
CEO
Dr. Cameron Geoffrey McDonough M.D.
Employees
150
Industry
Biotechnology
Sector
Healthcare
Market cap
$173M
Company details
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
Revenue
Revenue (Rev)
$13.17M
Stock vs Industry average
-
Industry average
Negative values are hidden from the graph.
Trailing annual dividend rate
$0.00
Payout ratio
0.00%
EPS
-$1.86
Margin profit
0.00%
52 week low
$0.9143
52 week high
$4.35
50-day simple moving average
$2.53
200-day simple moving average
$2.63
Percent held by insiders
14.52%
Percent held by institutions
84.32%
Dividend yield
0.00%
